In this episode of Cannabis Unlocked, Josh Rubin (CEO of Day Three Labs) and Tiby Erdely (KEY Founding Partner) discuss the needed evolution of cannabis products to increase consumer and patient outcomes. This conversation starts with an overview of Josh's journey into cannabis, the story behind Day Three Labs and their groundbreaking technology Unlokt. From there, Josh and Tiby speak to the importance of consistent dosing and effect of cannabis in relation to consumer experience and patient efficacy. The talk continues by diving into the science behind Day Three Labs' Unlokt technology and how it improves cannabis ingestibles by breaking down and stabilizing cannabinoids and terpenes in these products. The conversation wraps up with the research efforts Day Three Labs is conducting through their pharmaceutical lab in Israel. Please enjoy!